Smarter Drug Management, Stronger Practices
By Kurt Defenbaugh
May 18, 2026
How a sound drug strategy can drive both practice profitability and independence
5 min read
False
Advertisement
Business and Entrepreneurship
Theialife Appoints New CEO
May 18, 2026
Ahead of phase 3 myopia push, late clinical-stage biopharmaceutical company takes on Thomas Ruggia as Chief Executive Officer
1 min read
Cell Therapy Trial Targets Corneal Disease
May 4, 2026
Aurion Biotech launches phase 3 trial for corneal endothelial cell therapy
1 min read
Ocugen GA Trial Advances Toward Phase 3
May 1, 2026
Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy
1 min read
Why Smart Eye Surgeons Still Make Bad Growth Decisions
By Rod Solar
April 30, 2026
You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey
4 min read
Permanent J-Code for Epioxa
April 22, 2026
Glaukos secures permanent J-code from CMS ahead of July rollout
2 min read
Integrating EyeCare
April 20, 2026
As demand for ophthalmic services surges, EyeCare Partners is building a physician-led network designed to meet rising clinical and research needs
7 min read
Introducing: Moorfields and UCL Centre for Eye Health
April 17, 2026
New London eye health centre named ahead of 2027 summer opening
2 min read
Radical Transparency: The Future of Ophthalmic Practice
By
April 16, 2026
As patient expectations and legal scrutiny rise, ophthalmology must strive to measure and document every step of care
4 min read
Farid Takes Helm of Aurion MAB
March 27, 2026
Aurion Biotech names Marjan Farid chair of medical advisory board
2 min read
Browse by Subspecialties
False
Advertisement